IP Library Granted Patent US 12,420,074
Granted Patent B2
US 12,420,074 · App. 18/351,643 · Granted Sep 23, 2025

Fluid connector assembly

Inventors: Mohammed Mehtab Khan (Bengaluru, IN); Seyed Alireza Salehi Borojerdi (Aliso Viejo, CA)
Assignee: CAREFUSION 303, INC.
A61M39/10A61M39/1011A61M39/26A61M2039/1027A61M2039/1061A61M2039/267
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,420,074
App. No.
18/351,643
Granted
Sep 23, 2025
Kind
B2
Abstract

Fluid connector assemblies that seal off fluid paths in the respective connectors are disclosed. When connectors of a fluid connector assembly are connected to each other, respective compressible members in the connectors are displaced, allowing downstream fluid passage through the fluid connector assembly. The fluid connector assemblies may further include a coupling mechanism for providing a connection between the connectors and maintain a connection that provides a threshold retention force. When an external force greater than the threshold force is applied to the fluid connector assembly, the connectors may be decoupled while the coupling mechanism may remain intact.

Claims (43)

1. A coupling mechanism for a fluid connector assembly having a first connector and a second connector, the coupling mechanism comprising:

a first member having a first end and a second end opposite the first end; and

a second member comprising:

a first end configured to detachably couple to the second end of the first member; and

a second end opposite the first end, the second end having an opening and one or more ribs and at least one projection configured to flex with respect to another portion of the second member,

wherein the one or more ribs are disposed along a perimeter of the opening and extend inwardly towards a center of the opening for engaging a portion of the fluid connector assembly,

wherein the at least one projection extends inwardly toward the center of the opening of the second member and is configured to couple to a portion of the second connector of the fluid connector assembly, and

wherein, when the coupling mechanism is coupled to the fluid connector assembly, an end of the fluid connector assembly extends beyond the second end of the second member.

2. The coupling mechanism of claim 1 , wherein first member further comprises a first coupling portion and the second member further comprises a second coupling portion, and

wherein, when the first member and the second member are coupled, an exterior surface of the first coupling portion mates with an interior surface of the second coupling portion.

3. The coupling mechanism of claim 2 , wherein the first coupling portion and the second coupling portion are threaded.

4. The coupling mechanism of claim 1 , wherein the at least one projection is disposed at a position closer to the second end of the second member than the one or more ribs.

5. The coupling mechanism of claim 1 , wherein the second member is configured to detach from the second connector of the fluid connector assembly upon a separating force exceeding a predetermined threshold.

6. The coupling mechanism of claim 1 , wherein the one or more ribs comprise a first rib disposed along a first side of the perimeter and a second rib disposed along a second side of the perimeter opposite the first side, and wherein each of the first rib and the second rib include a concave portion.

7. A fluid connector assembly comprising:

a first connector;

a second connector for coupling to the first connector; and

a coupling mechanism configured to couple to the first connector, the coupling mechanism having:

a first member having a first end and a second end opposite the first end;

a second member having a first end configured to detachably couple to the second end of the first member and a second end opposite the first end and having at least one rib,

wherein, when the coupling mechanism is coupled to the first connector, at least a portion of the first connector is disposed within an interior cavity formed by the coupling mechanism, and

wherein, when the coupling mechanism is coupled to the first connector, the at least one rib contacts an exterior surface of the first connector.

8. The fluid connector assembly of claim 7 , wherein the second member further comprises at least one projection disposed at the second end,

and wherein the at least one projection is configured to contact a portion of the second connector when the coupling mechanism is coupled to the first connector and the first connector is coupled to the second connector.

9. The fluid connector assembly of claim 8 , wherein the at least one projection is configured to flex with respect to another portion of the second member.

10. The fluid connector assembly of claim 7 , wherein first member further comprises a first coupling portion and the second member further comprises a second coupling portion, and

wherein, when the first member and the second member are coupled, an exterior surface of the first coupling portion mates with an interior surface of the second coupling portion.

11. The coupling mechanism of claim 10 , wherein the first coupling portion and the second coupling portion are threaded.

12. The coupling mechanism of claim 7 , wherein the second member is configured to detach from the second connector of the the fluid connector assembly upon a separating force exceeding a predetermined threshold.

13. A method for coupling a fluid connecting assembly, the method comprising:

providing a first connector having a first end and a second end opposite the first end and a second connector;

providing a coupling mechanism having:

a first member having a first end and a second end opposite the first end;

a second member having a first end configured to detachably couple to the second end of the first member and a second end opposite the first end and having at least one rib;

positioning the first end of the first connector within an interior of the first member of the coupling mechanism;

detachably coupling the first member to the second member such that the first connector is substantially disposed within an interior cavity of the coupling mechanism; and

coupling the second connector to the first connector thereby forming a fluid pathway between the first connector and the second connector.

14. The method of claim 13 , wherein, detachably coupling the first member to the second member comprises coupling a first coupling portion of the first member and a second coupling portion of the second member via a threaded connection.

15. The method of claim 13 , wherein, when the first connector is disposed within the interior cavity of the coupling mechanism, the at least one rib contacts an exterior surface of the first connector.

16. The method of claim 13 , wherein the second member further comprises at least one projection disposed on an interior surface of the second member proximate the second end, and

wherein the at least one projection extends inwardly toward a center of an opening of the second member.

17. The method of claim 16 , wherein, when the second connector is coupled to the first connector, the at least one projection contacts an exterior surface of the second connector.

18. The method of claim 13 , wherein the second member is configured to detach from the second connector of the fluid connecting assembly upon a separating force exceeding a predetermined threshold.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2023
From: KHAN, MOHAMMED MEHTAB; SALEHI BOROJERDI, SEYED ALIREZA
To: CAREFUSION 303, INC.
Reel/Frame 064685/0663 →
Continuity (1)
Related Publication 20250020256A1 · Jan 16, 2025
References Cited (164)
US 5713856A · Eggers et al. · 1998 [cited by applicant]
US 6874522B2 · Anderson et al. · 2005 [cited by applicant]
US 7004934B2 · Vaillancourt · 2006 [cited by applicant]
US 7040598B2 · Raybuck · 2006 [cited by applicant]
US 7153296B2 · Mitchell · 2006 [cited by applicant]
US 7350764B2 · Raybuck · 2008 [cited by applicant]
US 7396051B2 · Baldwin et al. · 2008 [cited by applicant]
US 7731244B2 · Miros et al. · 2010 [cited by applicant]
US 7763013B2 · Baldwin et al. · 2010 [cited by applicant]
US 7766394B2 · Sage et al. · 2010 [cited by applicant]
US 7794675B2 · Lynn · 2010 [cited by applicant]
US 7803139B2 · Fangrow, Jr. · 2010 [cited by applicant]
US 7803140B2 · Fangrow, Jr. · 2010 [cited by applicant]
US 7815614B2 · Fangrow, Jr. · 2010 [cited by applicant]
US 7918243B2 · Diodati et al. · 2011 [cited by applicant]
US 7998134B2 · Fangrow et al. · 2011 [cited by applicant]
US 8123738B2 · Vaillancourt · 2012 [cited by applicant]
US 8142418B2 · Mcmichael et al. · 2012 [cited by applicant]
US 8211069B2 · Fangrow, Jr. · 2012 [cited by applicant]
US 8262628B2 · Fangrow, Jr. · 2012 [cited by applicant]
US 8361408B2 · Lynn · 2013 [cited by applicant]
US 8480968B2 · Lynn · 2013 [cited by applicant]
US 8777908B2 · Fangrow, Jr. · 2014 [cited by applicant]
US 8777909B2 · Fangrow, Jr. · 2014 [cited by applicant]
US 8795256B1 · Smith · 2014 [cited by examiner]
US 8888758B2 · Mansour · 2014 [cited by applicant]
US 8899267B2 · Diodati et al. · 2014 [cited by applicant]
US 8910919B2 · Bonnal et al. · 2014 [cited by applicant]
US 8974425B2 · Tachizaki et al. · 2015 [cited by applicant]
US 8974437B2 · Williams · 2015 [cited by examiner]
US 9114242B2 · Fangrow et al. · 2015 [cited by applicant]
US 9126028B2 · Fangrow et al. · 2015 [cited by applicant]
US 9126029B2 · Fangrow et al. · 2015 [cited by applicant]
US 9192753B2 · Lopez et al. · 2015 [cited by applicant]
US 9234616B2 · Carrez et al. · 2016 [cited by applicant]
US 9358379B2 · Fangrow, Jr. · 2016 [cited by applicant]
US 9433769B2 · Bayly · 2016 [cited by applicant]
US 9468749B2 · Mansour et al. · 2016 [cited by applicant]
US 9492649B2 · Carrez et al. · 2016 [cited by applicant]
US 9636492B2 · Fangrow, Jr. · 2017 [cited by applicant]
US 9724504B2 · Fangrow, Jr. et al. · 2017 [cited by applicant]
US 9724505B2 · Williams et al. · 2017 [cited by applicant]
US 9861805B2 · Dennis et al. · 2018 [cited by applicant]
US 9933094B2 · Fangrow · 2018 [cited by examiner]
US 9974939B2 · Fangrow, Jr. · 2018 [cited by applicant]
US 9974940B2 · Fangrow, Jr. · 2018 [cited by applicant]
US 10029086B2 · Nowak et al. · 2018 [cited by applicant]
US 10156306B2 · Fangrow · 2018 [cited by applicant]
US 10173045B2 · Mansour · 2019 [cited by applicant]
US 10179203B1 · Huslage et al. · 2019 [cited by applicant]
US 10315025B2 · Phillips · 2019 [cited by examiner]
US 10398887B2 · Fangrow, Jr. et al. · 2019 [cited by applicant]
US 10441507B2 · Sanders · 2019 [cited by applicant]
US 10518078B2 · Stjernberg Bejhed et al. · 2019 [cited by applicant]
US 10569073B2 · Hallisey · 2020 [cited by examiner]
US 10625068B2 · Leuthardt et al. · 2020 [cited by applicant]
US 10655768B2 · Jones · 2020 [cited by examiner]
US 10697570B2 · Fangrow · 2020 [cited by applicant]
US 10744315B2 · Sanders · 2020 [cited by applicant]
US 10842982B2 · Fangrow, Jr. · 2020 [cited by applicant]
US 10857346B2 · Dennis et al. · 2020 [cited by applicant]
US 10864362B2 · Jones · 2020 [cited by examiner]
US 10881847B2 · Lynn · 2021 [cited by applicant]
US 11168818B2 · Fangrow · 2021 [cited by applicant]
US 11207514B2 · Kakinoki · 2021 [cited by applicant]
US 11235135B2 · Tsai · 2022 [cited by applicant]
US 11273297B2 · Kakinoki · 2022 [cited by applicant]
US 11484471B2 · Sanders · 2022 [cited by applicant]
US 11491084B2 · Ueda et al. · 2022 [cited by applicant]
US 11708924B2 · Mansour · 2023 [cited by examiner]
US 12023462B2 · Kumar · 2024 [cited by examiner]
US 12109387B2 · Feith · 2024 [cited by examiner]
US 20040215158A1 · Anderson · 2004 [cited by applicant]
US 20050090805A1 · Shaw et al. · 2005 [cited by applicant]
US 20060129109A1 · Shaw · 2006 [cited by examiner]
US 20070088292A1 · Fangrow · 2007 [cited by applicant]
US 20070088293A1 · Fangrow · 2007 [cited by applicant]
US 20070088294A1 · Fangrow · 2007 [cited by applicant]
US 20070225635A1 · Lynn · 2007 [cited by applicant]
US 20080039803A1 · Lynn · 2008 [cited by applicant]
US 20110106046A1 · Hiranuma · 2011 [cited by applicant]
US 20110204621A1 · Whitaker et al. · 2011 [cited by applicant]
US 20140249487A1 · Lynn · 2014 [cited by applicant]
US 20140330254A1 · Rosenberger et al. · 2014 [cited by applicant]
US 20160000363A1 · Jones et al. · 2016 [cited by applicant]
US 20180200147A1 · Sanders · 2018 [cited by applicant]
US 20190184152A1 · Kakinoki · 2019 [cited by applicant]
US 20190282797A1 · Tsai · 2019 [cited by applicant]
US 20200113784A1 · Lopez et al. · 2020 [cited by applicant]
US 20200179672A1 · Kakinoki · 2020 [cited by applicant]
US 20200215319A1 · Fangrow, Jr. et al. · 2020 [cited by applicant]
US 20200284385A1 · Fangrow · 2020 [cited by applicant]
US 20200323734A1 · Ueda et al. · 2020 [cited by applicant]
US 20200338331A1 · Sanders · 2020 [cited by applicant]
US 20210069484A1 · Tsa · 2021 [cited by applicant]
US 20210077803A1 · Lynn · 2021 [cited by applicant]
US 20210252267A1 · Fangrow, Jr. · 2021 [cited by applicant]
US 20210268255A1 · O'Neil · 2021 [cited by applicant]
US 20210388926A1 · Martin et al. · 2021 [cited by applicant]
US 20210393938A1 · Lynn et al. · 2021 [cited by applicant]
US 20210404587A1 · Mansour · 2021 [cited by examiner]
US 20220260189A1 · Deuse · 2022 [cited by examiner]
US 20220282814A1 · Fangrow · 2022 [cited by applicant]
US 20230149689A1 · Armstrong · 2023 [cited by examiner]
US 20230310824A1 · Shauver · 2023 [cited by examiner]
EP 1678070A2 · 2006 [cited by applicant]
EP 1517723B1 · 2007 [cited by applicant]
EP 1622675B1 · 2009 [cited by applicant]
EP 2144634A1 · 2010 [cited by applicant]
EP 2298407A1 · 2011 [cited by applicant]
EP 2694132A1 · 2014 [cited by applicant]
EP 2562456B1 · 2014 [cited by applicant]
EP 2782633A1 · 2014 [cited by applicant]
EP 1842002B1 · 2015 [cited by applicant]
EP 2736582B1 · 2015 [cited by applicant]
EP 2089094B1 · 2016 [cited by applicant]
EP 2219721B1 · 2017 [cited by applicant]
EP 2753396B1 · 2017 [cited by applicant]
EP 2736584B1 · 2018 [cited by applicant]
EP 3305361A1 · 2018 [cited by applicant]
EP 2271398B1 · 2018 [cited by applicant]
EP 2480281B1 · 2018 [cited by applicant]
EP 2790750B1 · 2018 [cited by applicant]
EP 2331191B1 · 2019 [cited by applicant]
EP 3079756B1 · 2019 [cited by applicant]
EP 2121114B1 · 2019 [cited by applicant]
EP 2719419B1 · 2019 [cited by applicant]
EP 2956204B1 · 2019 [cited by applicant]
EP 3421077B1 · 2019 [cited by applicant]
EP 3530313A1 · 2019 [cited by applicant]
EP 3538201A1 · 2019 [cited by applicant]
EP 3570807A1 · 2019 [cited by applicant]
EP 3570809A1 · 2019 [cited by applicant]
EP 2536463B1 · 2020 [cited by applicant]
EP 3381505B1 · 2020 [cited by applicant]
EP 3538201B1 · 2020 [cited by applicant]
EP 1904152B1 · 2020 [cited by applicant]
EP 2150307B1 · 2020 [cited by applicant]
EP 3313490B1 · 2021 [cited by applicant]
EP 3760275A1 · 2021 [cited by applicant]
EP 3851155A1 · 2021 [cited by applicant]
EP 3517164B1 · 2021 [cited by applicant]
EP 3954355A1 · 2022 [cited by applicant]
EP 3960229A1 · 2022 [cited by applicant]
EP 3973044A1 · 2022 [cited by applicant]
EP 3305361B1 · 2022 [cited by applicant]
EP 3134052B1 · 2022 [cited by applicant]
EP 3530313B1 · 2022 [cited by applicant]
WO WO2021099437A1 · 2021 [cited by applicant]
WO WO2021180675A1 · 2021 [cited by applicant]
WO WO2021252197A1 · 2021 [cited by applicant]
WO WO2022042956A1 · 2022 [cited by applicant]
WO WO2022149339A1 · 2022 [cited by examiner]
WO WO2022207560A1 · 2022 [cited by applicant]
Bangert, Bill, “Shorter times to blood transfusion associated with decreased death risk in trauma patients”, Medical Xpress, Apr. 14, 2016, https://medicalxpress.com/news/2016-04-shorter-blood-transfusion-decreased-deat… [cited by applicant]
Icumedical, “ChemoClave™ Needlefree Close System Transfer Device (CSTD)”, date unknown, https://www.icumed.com/products/oncology/closed-system-transfer-devices/chemoclave. [cited by applicant]
Icumedical, “ChemoLock™ Needlefree Closed System Transfer Device (CSTD)”, date unknown, https://www.icumed.com/products/oncology/closed-system-transfer-devices/chemolock. [cited by applicant]
Ivteam, “Force-activated separation IV connectors”, 2022, Retrieved from the internet https://www.ivteam.com/intravenous-literature/force-activated-separation-iv-connectors/ [Last retrieved Jan. 13, 2023]. [cited by applicant]
Lineus Medical, SafeBreak Product Features and Benefits Brochure, May 2021, mkg 0058 May 2021 Rev. 02. [cited by applicant]
Przen, “Lineus Medical Goes International, Signs ONEY for Distribution in Korea”, PRZen Online Press Release Distribution, PrZen/33448014, MKG-0130 Rev 00, Retrieved from the internet https://przen.com/pr/lineus-medical… [cited by applicant]
Rickard, et al., “Securing All intraVenous devices Effectively in hospitalised patients—the SAVE trial: study protocol for a multicentre randomised controlled trial”, BMJ Open, Sep. 23, 2015;5(9):e008689, doi: 10.1136/b… [cited by applicant]
TADA Group AB, LinkedIn Post “ReLink granted patent in Japan”, LinkedIn, Mar. 2022, retrieved from the internet https://se.linkedin.com/company/tadamedical?trk=public_post_reshare_feed-actor-image&original_referer= [Las… [cited by applicant]
Tribology, “Coefficient of friction, Rolling resistance and Aerodynamics”, date unknown, https://www.tribology-abc.com/abc/cof.htm. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2024/037208, dated Oct. 2, 2024, 11 pages. [cited by applicant]